LAM
L2 Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.77M | Buy |
20,328
+2,296
| +13% | +$426K | 0.62% | 53 |
|
|
2025
Q1 | $3.78M | Buy |
18,032
+3,404
| +23% | +$713K | 0.77% | 46 |
|
|
2024
Q4 | $2.6M | Buy |
14,628
+140
| +1% | +$24.9K | 0.57% | 54 |
|
|
2024
Q3 | $2.86M | Buy |
14,488
+1,936
| +15% | +$382K | 0.78% | 42 |
|
|
2024
Q2 | $2.15M | Buy |
12,552
+5,918
| +89% | +$1.02M | 0.65% | 46 |
|
|
2024
Q1 | $1.21M | Buy |
6,634
+1,692
| +34% | +$308K | 0.4% | 65 |
|
|
2023
Q4 | $766K | Buy |
4,942
+4,576
| +1,250% | +$709K | 0.31% | 74 |
|
|
2023
Q3 | $902K | Sell |
366
-11,650
| -97% | -$28.7M | 0.42% | 68 |
|
|
2023
Q2 | $1.6M | Buy |
12,016
+1,673
| +16% | +$223K | 0.78% | 44 |
|
|
2023
Q1 | $1.65M | Sell |
10,343
-1,163
| -10% | -$185K | 0.91% | 31 |
|
|
2022
Q4 | $1.86M | Hold |
11,506
| – | – | 1.16% | 27 |
|
|
2022
Q3 | $1.54M | Buy |
11,506
+407
| +4% | +$54.6K | 1.06% | 35 |
|
|
2022
Q2 | $1.7M | Buy |
11,099
+1,623
| +17% | +$249K | 1.23% | 31 |
|
|
2022
Q1 | $1.54M | Buy |
9,476
+4,213
| +80% | +$683K | 0.88% | 37 |
|
|
2021
Q4 | $713K | Buy |
5,263
+1,254
| +31% | +$170K | 0.5% | 58 |
|
|
2021
Q3 | $432K | Sell |
4,009
-960
| -19% | -$103K | 1.09% | 40 |
|
|
2021
Q2 | $560K | Sell |
4,969
-1,217
| -20% | -$137K | 0.52% | 61 |
|
|
2021
Q1 | $669K | Sell |
6,186
-5,121
| -45% | -$554K | 0.69% | 54 |
|
|
2020
Q4 | $1.21M | Sell |
11,307
-2,313
| -17% | -$248K | 0.83% | 34 |
|
|
2020
Q3 | $1.19M | Sell |
13,620
-12,812
| -48% | -$1.12M | 0.96% | 34 |
|
|
2020
Q2 | $2.6M | Buy |
26,432
+764
| +3% | +$75K | 2.35% | 12 |
|
|
2020
Q1 | $1.96M | Buy |
25,668
+7,223
| +39% | +$550K | 2.2% | 19 |
|
|
2019
Q4 | $1.63M | Buy |
+18,445
| New | +$1.63M | 1.43% | 34 |
|